Abbott (ABT) Stock Price & AI Analysis

NASDAQ
USA

$115.60

$22.97
(1.86%)

Subscribe to get
AI Score

Abbott Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Abbott | Latest news

Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note

The latest trading session saw Abbott (ABT) ending at $115.59, denoting a -0.33% adjustment from its...

Zacks - 3 days ago

Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up

Put simply, these types of businesses are compounding machines, meaning they are continually...

Simply Wall St - 4 days ago

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...

Zacks - 5 days ago

Brokers Suggest Investing in Abbott (ABT): Read This Before Placing a Bet

The average brokerage recommendation (ABR) for Abbott (ABT) is equivalent to a Buy. The overly...

Zacks - 4 days ago

Zane Maloney is Excited To Take On First Formula E Weekend with ABT Lola-Yamaha

The 19-year-old Barbados driver is set to make his race debut in Formula E as he begins new...

Athlon Sports - 2 days ago

Abbott's SWOT analysis: stock resilience amid litigation challenges By...

Abbott Laboratories (NYSE:ABT), a leading player in the medical devices and healthcare products...

Investingcom - 5 days ago

Cupra to remain in Formula E with American Kiro team

Cupra's absence from Formula E barely lasted the offseason. After splitting with Abt following two seasons, with the German teamnow partnered with Lola...

Racer - 6 days ago

Abbott Laboratories and Big Ten's Blood Drive Competition: A Lif

Abbott Laboratories (ABT, Financial) announced the successful conclusion of its inaugural "We Give Blood Drive" competition in partnership with the Big Ten Conference, held during the college ...

Guru Focus - 1 day ago

Abbott Laboratories (NYSE:ABT) Short Interest Down 14.4% in November

Abbott Laboratories (NYSE:ABT – Get Free Report) saw a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 12,050,000 shares ...

ETF DAILY NEWS - 6 days ago

Chicago shoppers aren’t worried about tariffs yet, but say they will be alert to...

With incoming President Donald Trump promising to impose tariffs on imported goods, economists say...

Chicago Tribune - 6 days ago